ResearcherHarvard UniversityNo recent work listed
Zhi Rong Qian
Matched on ORCID iD 0000-0003-1633-4120; OpenAlex author ID A5088794081. Sources: OpenAlex.
Their work
- Papers
- 16 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 49
2013: 3 papers · 2014: 2 papers · 2015: 1 paper · 2016: 3 papers · 2017: 3 papers · 2018: 3 papers · 2019: 1 paper
Papers 16
- Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected pancreatic cancer. Co-author DOI 10.1038/s41436-018-0009-5↗
- Association of Alterations in Main Driver Genes With Outcomes of Patients With Resected Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1001/jamaoncol.2017.3420↗
- Statin use and pancreatic cancer risk in two prospective cohort studies. Co-author DOI 10.1007/s00535-018-1430-x↗
- Prediagnosis Use of Statins Associates With Increased Survival Times of Patients With Pancreatic Cancer. Co-author DOI 10.1016/j.cgh.2018.02.022↗
- Lymph node metastases in resected pancreatic ductal adenocarcinoma: predictors of disease recurrence and survival. Co-author DOI 10.1038/bjc.2017.349↗
- Leucocyte telomere length, genetic variants at the TERT gene region and risk of pancreatic cancer. Co-author DOI 10.1136/gutjnl-2016-312510↗
- Cigarette Smoking and Pancreatic Cancer Survival. Co-author DOI 10.1200/jco.2016.71.2026↗
- Circulating Metabolites and Survival Among Patients With Pancreatic Cancer. Co-author DOI 10.1093/jnci/djv409↗
- Pancreatic Cancer Risk Associated with Prediagnostic Plasma Levels of Leptin and Leptin Receptor Genetic Polymorphisms. Co-author DOI 10.1158/0008-5472.can-16-1699↗
- Prediagnostic Plasma 25-Hydroxyvitamin D and Pancreatic Cancer Survival. First author DOI 10.1200/jco.2015.66.3005↗
- Survival among patients with pancreatic cancer and long-standing or recent-onset diabetes mellitus. Co-author DOI 10.1200/jco.2014.57.5688↗
- Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development. Co-author DOI 10.1038/nm.3686↗
- Genome-wide association study of survival in patients with pancreatic adenocarcinoma. Co-author DOI 10.1136/gutjnl-2012-303477↗
- Hyperglycemia, insulin resistance, impaired pancreatic β-cell function, and risk of pancreatic cancer. Co-author DOI 10.1093/jnci/djt123↗
- Inflammatory plasma markers and pancreatic cancer risk: a prospective study of five U.S. cohorts. Co-author DOI 10.1158/1055-9965.epi-12-1458↗
- Prediagnostic body mass index and pancreatic cancer survival. Co-author DOI 10.1200/jco.2013.51.7532↗
Closest collaborators
The 25 strongest of 49 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Brian Matthew Wolpin · 15 shared papers, 2013–2019 · strength 0.68
- Paper Statin use and pancreatic cancer risk in two prospective cohort studies. DOI 10.1007/s00535-018-1430-x↗
- Paper Prediagnosis Use of Statins Associates With Increased Survival Times of Patients With Pancreatic Cancer. DOI 10.1016/j.cgh.2018.02.022↗
- Paper Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected panc… DOI 10.1038/s41436-018-0009-5↗
- Charles S. Fuchs · 14 shared papers, 2013–2019 · strength 0.65
- Paper Statin use and pancreatic cancer risk in two prospective cohort studies. DOI 10.1007/s00535-018-1430-x↗
- Paper Prediagnosis Use of Statins Associates With Increased Survival Times of Patients With Pancreatic Cancer. DOI 10.1016/j.cgh.2018.02.022↗
- Paper Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected panc… DOI 10.1038/s41436-018-0009-5↗
- Chen Yuan · 13 shared papers, 2013–2019 · strength 0.63
- Paper Statin use and pancreatic cancer risk in two prospective cohort studies. DOI 10.1007/s00535-018-1430-x↗
- Paper Prediagnosis Use of Statins Associates With Increased Survival Times of Patients With Pancreatic Cancer. DOI 10.1016/j.cgh.2018.02.022↗
- Paper Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected panc… DOI 10.1038/s41436-018-0009-5↗
- Kimmie Ng · 11 shared papers, 2013–2018 · strength 0.54
- Paper Statin use and pancreatic cancer risk in two prospective cohort studies. DOI 10.1007/s00535-018-1430-x↗
- Paper Prediagnosis Use of Statins Associates With Increased Survival Times of Patients With Pancreatic Cancer. DOI 10.1016/j.cgh.2018.02.022↗
- Paper Cigarette Smoking and Pancreatic Cancer Survival. DOI 10.1200/jco.2016.71.2026↗
- Douglas Adam Rubinson · 11 shared papers, 2013–2019 · strength 0.53
- Paper Statin use and pancreatic cancer risk in two prospective cohort studies. DOI 10.1007/s00535-018-1430-x↗
- Paper Prediagnosis Use of Statins Associates With Increased Survival Times of Patients With Pancreatic Cancer. DOI 10.1016/j.cgh.2018.02.022↗
- Paper Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected panc… DOI 10.1038/s41436-018-0009-5↗
- Edward L. Giovannucci · 12 shared papers, 2013–2018 · strength 0.53
- Paper Statin use and pancreatic cancer risk in two prospective cohort studies. DOI 10.1007/s00535-018-1430-x↗
- Paper Prediagnosis Use of Statins Associates With Increased Survival Times of Patients With Pancreatic Cancer. DOI 10.1016/j.cgh.2018.02.022↗
- Paper Cigarette Smoking and Pancreatic Cancer Survival. DOI 10.1200/jco.2016.71.2026↗
- Peter Kraft · 12 shared papers, 2013–2018 · strength 0.53
- Paper Statin use and pancreatic cancer risk in two prospective cohort studies. DOI 10.1007/s00535-018-1430-x↗
- Paper Prediagnosis Use of Statins Associates With Increased Survival Times of Patients With Pancreatic Cancer. DOI 10.1016/j.cgh.2018.02.022↗
- Paper Cigarette Smoking and Pancreatic Cancer Survival. DOI 10.1200/jco.2016.71.2026↗
- Vicente Morales‐Oyarvide · 9 shared papers, 2016–2019 · strength 0.49
- Paper Statin use and pancreatic cancer risk in two prospective cohort studies. DOI 10.1007/s00535-018-1430-x↗
- Paper Prediagnosis Use of Statins Associates With Increased Survival Times of Patients With Pancreatic Cancer. DOI 10.1016/j.cgh.2018.02.022↗
- Paper Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected panc… DOI 10.1038/s41436-018-0009-5↗
- Ana Babić · 8 shared papers, 2016–2018 · strength 0.43
- Paper Statin use and pancreatic cancer risk in two prospective cohort studies. DOI 10.1007/s00535-018-1430-x↗
- Paper Prediagnosis Use of Statins Associates With Increased Survival Times of Patients With Pancreatic Cancer. DOI 10.1016/j.cgh.2018.02.022↗
- Paper Cigarette Smoking and Pancreatic Cancer Survival. DOI 10.1200/jco.2016.71.2026↗
- JoAnn E. Manson · 8 shared papers, 2013–2017 · strength 0.32
- Paper Cigarette Smoking and Pancreatic Cancer Survival. DOI 10.1200/jco.2016.71.2026↗
- Paper Leucocyte telomere length, genetic variants at the TERT gene region and risk of pancreatic cancer. DOI 10.1136/gutjnl-2016-312510↗
- Paper Prediagnostic Plasma 25-Hydroxyvitamin D and Pancreatic Cancer Survival. DOI 10.1200/jco.2015.66.3005↗
- Jonathan Andrew Nowak · 5 shared papers, 2017–2019 · strength 0.29
- Paper Statin use and pancreatic cancer risk in two prospective cohort studies. DOI 10.1007/s00535-018-1430-x↗
- Paper Prediagnosis Use of Statins Associates With Increased Survival Times of Patients With Pancreatic Cancer. DOI 10.1016/j.cgh.2018.02.022↗
- Paper Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected panc… DOI 10.1038/s41436-018-0009-5↗
- Natalia I. Khalaf · 5 shared papers, 2017–2019 · strength 0.29
- Paper Statin use and pancreatic cancer risk in two prospective cohort studies. DOI 10.1007/s00535-018-1430-x↗
- Paper Prediagnosis Use of Statins Associates With Increased Survival Times of Patients With Pancreatic Cancer. DOI 10.1016/j.cgh.2018.02.022↗
- Paper Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected panc… DOI 10.1038/s41436-018-0009-5↗
- Ying Bao · 6 shared papers, 2013–2017 · strength 0.21
- Paper Leucocyte telomere length, genetic variants at the TERT gene region and risk of pancreatic cancer. DOI 10.1136/gutjnl-2016-312510↗
- Paper Pancreatic Cancer Risk Associated with Prediagnostic Plasma Levels of Leptin and Leptin Receptor Genetic Polymorphisms. DOI 10.1158/0008-5472.can-16-1699↗
- Paper Prediagnostic body mass index and pancreatic cancer survival. DOI 10.1200/jco.2013.51.7532↗
- Thomas E. Clancy · 4 shared papers, 2015–2019 · strength 0.20
- Paper Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected panc… DOI 10.1038/s41436-018-0009-5↗
- Paper Association of Alterations in Main Driver Genes With Outcomes of Patients With Resected Pancreatic Ductal Adenocarcinom… DOI 10.1001/jamaoncol.2017.3420↗
- Paper Lymph node metastases in resected pancreatic ductal adenocarcinoma: predictors of disease recurrence and survival. DOI 10.1038/bjc.2017.349↗
- Chen Hsuan Wu · 6 shared papers, 2013–2016 · strength 0.20
- Paper Circulating Metabolites and Survival Among Patients With Pancreatic Cancer. DOI 10.1093/jnci/djv409↗
- Paper Survival among patients with pancreatic cancer and long-standing or recent-onset diabetes mellitus. DOI 10.1200/jco.2014.57.5688↗
- Paper Prediagnostic body mass index and pancreatic cancer survival. DOI 10.1200/jco.2013.51.7532↗
- David C. Linehan · 3 shared papers, 2017–2019 · strength 0.16
- Paper Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected panc… DOI 10.1038/s41436-018-0009-5↗
- Paper Association of Alterations in Main Driver Genes With Outcomes of Patients With Resected Pancreatic Ductal Adenocarcinom… DOI 10.1001/jamaoncol.2017.3420↗
- Paper Lymph node metastases in resected pancreatic ductal adenocarcinoma: predictors of disease recurrence and survival. DOI 10.1038/bjc.2017.349↗
- Albert C. Koong · 3 shared papers, 2017–2019 · strength 0.16
- Paper Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected panc… DOI 10.1038/s41436-018-0009-5↗
- Paper Association of Alterations in Main Driver Genes With Outcomes of Patients With Resected Pancreatic Ductal Adenocarcinom… DOI 10.1001/jamaoncol.2017.3420↗
- Paper Lymph node metastases in resected pancreatic ductal adenocarcinoma: predictors of disease recurrence and survival. DOI 10.1038/bjc.2017.349↗
- Richard Francis Dunne · 3 shared papers, 2017–2019 · strength 0.16
- Paper Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected panc… DOI 10.1038/s41436-018-0009-5↗
- Paper Association of Alterations in Main Driver Genes With Outcomes of Patients With Resected Pancreatic Ductal Adenocarcinom… DOI 10.1001/jamaoncol.2017.3420↗
- Paper Lymph node metastases in resected pancreatic ductal adenocarcinoma: predictors of disease recurrence and survival. DOI 10.1038/bjc.2017.349↗
- Andrea J. Bullock · 3 shared papers, 2017–2019 · strength 0.16
- Paper Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected panc… DOI 10.1038/s41436-018-0009-5↗
- Paper Association of Alterations in Main Driver Genes With Outcomes of Patients With Resected Pancreatic Ductal Adenocarcinom… DOI 10.1001/jamaoncol.2017.3420↗
- Paper Lymph node metastases in resected pancreatic ductal adenocarcinoma: predictors of disease recurrence and survival. DOI 10.1038/bjc.2017.349↗
- Margaret M. Kozak · 3 shared papers, 2017–2019 · strength 0.16
- Paper Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected panc… DOI 10.1038/s41436-018-0009-5↗
- Paper Association of Alterations in Main Driver Genes With Outcomes of Patients With Resected Pancreatic Ductal Adenocarcinom… DOI 10.1001/jamaoncol.2017.3420↗
- Paper Lymph node metastases in resected pancreatic ductal adenocarcinoma: predictors of disease recurrence and survival. DOI 10.1038/bjc.2017.349↗
- Daniel Tandel Chang · 3 shared papers, 2017–2019 · strength 0.16
- Paper Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected panc… DOI 10.1038/s41436-018-0009-5↗
- Paper Association of Alterations in Main Driver Genes With Outcomes of Patients With Resected Pancreatic Ductal Adenocarcinom… DOI 10.1001/jamaoncol.2017.3420↗
- Paper Lymph node metastases in resected pancreatic ductal adenocarcinoma: predictors of disease recurrence and survival. DOI 10.1038/bjc.2017.349↗
- Aram F. Hezel · 3 shared papers, 2017–2019 · strength 0.16
- Paper Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected panc… DOI 10.1038/s41436-018-0009-5↗
- Paper Association of Alterations in Main Driver Genes With Outcomes of Patients With Resected Pancreatic Ductal Adenocarcinom… DOI 10.1001/jamaoncol.2017.3420↗
- Paper Lymph node metastases in resected pancreatic ductal adenocarcinoma: predictors of disease recurrence and survival. DOI 10.1038/bjc.2017.349↗
- Tsuyoshi Hamada · 2 shared papers, 2018 · strength 0.14
- Laufey Thora Amundadottir · 3 shared papers, 2016–2017 · strength 0.13
- Paper Leucocyte telomere length, genetic variants at the TERT gene region and risk of pancreatic cancer. DOI 10.1136/gutjnl-2016-312510↗
- Paper Pancreatic Cancer Risk Associated with Prediagnostic Plasma Levels of Leptin and Leptin Receptor Genetic Polymorphisms. DOI 10.1158/0008-5472.can-16-1699↗
- Paper Circulating Metabolites and Survival Among Patients With Pancreatic Cancer. DOI 10.1093/jnci/djv409↗
- Michaël Pollak · 4 shared papers, 2013–2016 · strength 0.13
- Paper Pancreatic Cancer Risk Associated with Prediagnostic Plasma Levels of Leptin and Leptin Receptor Genetic Polymorphisms. DOI 10.1158/0008-5472.can-16-1699↗
- Paper Hyperglycemia, insulin resistance, impaired pancreatic β-cell function, and risk of pancreatic cancer. DOI 10.1093/jnci/djt123↗
- Paper Inflammatory plasma markers and pancreatic cancer risk: a prospective study of five U.S. cohorts. DOI 10.1158/1055-9965.epi-12-1458↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.